Vaccine stock to climb up to $140 in wave-3
At a weekly time frame, this stock is the next thing to blow out. With phase 3 trials expected in July, the potential of $MRNA could be huge in upcoming weeks.
With wave-1 and wave-2 already formed, market is now forming wave-3 which may lead the price to possibly $140-160 zone.
(Note: Please ignore the markings for wave-4 and wave-5)
What do you think about this idea? Leave your comments below.
Disclaimer: This is not a financial advise. Please make your independent decisions while making an investment.
With wave-1 and wave-2 already formed, market is now forming wave-3 which may lead the price to possibly $140-160 zone.
(Note: Please ignore the markings for wave-4 and wave-5)
What do you think about this idea? Leave your comments below.
Disclaimer: This is not a financial advise. Please make your independent decisions while making an investment.
Dagangan aktif
Dagangan ditutup secara manual:
Trade was closed earlier in August when $MRNA made a high of $95.21 and then dropped back to $60s breaking the trend line.